Ethics, economics, and the publication policies of major medical journals.

OBJECTIVE To evaluate aspects of the publication process that may affect the quality of the literature in clinical economics and biomedical ethics, and to learn about the policies of medical journals regarding disclosure of relationships between investigators and research sponsors. DESIGN Mail survey. PARTICIPANTS Editors in chief of 15 major medical journals. RESULTS Twelve editors responded to the survey. Ten reported having statisticians among their editors, while only two had health economists and none had ethicists. Clinicians in the specialty field were almost always the primary reviewers of submissions, while methodologists (statisticians, health economists, or ethicists) were involved less frequently. Journals reported little knowledge of the training of their reviewers in these fields. While nine journals requested disclosure of the financial relationship between author and sponsor, only one inquired whether the sponsor's written approval was required prior to manuscript submission, and only one knew whether there was an independent steering committee for the study. CONCLUSIONS These findings suggest that the peer review process can be strengthened to improve the quality of the medical literature in clinical economics and biomedical ethics. Journal editors also need to better understand the terms of research sponsorship agreements.

[1]  B. Brody Assessing empirical research in bioethics , 1993, Theoretical medicine.

[2]  A. Detsky,et al.  Should Canada and the United States Universally Vaccinate Infants against Hepatitis B? , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  Thomas C. Chalmers,et al.  Economic Analysis in Randomized Control Trials , 1992, Medical care.

[4]  G A Colditz,et al.  Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature , 1992, Annals of Internal Medicine.

[5]  B Kinosian,et al.  Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. , 1991, The New England journal of medicine.

[6]  B. Brody Quality of scholarship in bioethics. , 1990, The Journal of medicine and philosophy.

[7]  M. Southgate Conflict of interest and the peer review process. , 1987, JAMA.

[8]  Beauchamp Tl Ethics and Experts. 4. What philosophers can offer. , 1982 .